CDNA CareDx Inc: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

CareDx Inc - graphic logo of issuer CDNA

Medicare payment volatility is exerting significant pressure on profitability, as confirmed by the current EV/EBITDA valuation, where the parameter equals 144.86. This chart's price action correlates with concerns regarding test efficacy and certification delays for new methodologies. Meanwhile, CareDx, Inc (CDNA) revenue relies on AlloSure volumes and clinic loyalty, although risks of reduced insurance coverage remain critical.

CareDx, Inc - CDNA Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/12/2026)

Summary analytical data breakdowns for CareDx, Inc. (CDNA)

- stock price and consensus target price:
Stock Quotes caredx.com|CDNA - Average Forecast Price
- company stock capitalization data:
Market Value CareDx Health|CDNA - Company Buyout Price
- book value of equity indicators:
Book Value per Share CareDx|CDNA - Book Valuation of Business|Market Value to Book Value Ratio caredx.com|CDNA - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Capital CareDx, Inc|CDNA - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital CareDx Inc|CDNA - Company Aggregate Debts|Debt to Book Capitalization Ratio CareDx Health|CDNA - Company Long-Term Loans and Borrowings|Company Short-Term Debts CareDx|Quick Ratio caredx.com
- financial results and valuation multiples details:
CDNA - Company Profit|Future Profit CareDx, Inc|CDNA - Price to Earnings Multiple|Projected Price to Earnings CareDx, Inc|CDNA - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple CareDx Health|CDNA - Operating income before deduction of amortization|Earnings per share for the last twelve months CareDx|CDNA - Earnings per share for the last 12 months|Quarterly EPS earnings growth caredx.com|CDNA - Net earnings per share growth this year|Earnings growth forecast for next year CareDx, Inc
Fundamental company analysis:CDNA (CareDx Health)
Product sample of CareDx, Inc.

The EV/EBITDA ratio compares the total enterprise value of CareDx, Inc (CDNA), including net debt, with its operating profitability before depreciation and taxes, determining the real price of the asset relative to its generated cash flow. By analyzing the EV/EBITDA trajectory of CareDx, Inc (CDNA), an investor can assess whether the costs of robotizing diagnostic complexes and implementing autonomous DNA analysis are justified by the current efficiency of the business.

Key competitors

Agilent Tech - Enterprise Value to EBITDA Ratio|Quest Corp (DGX) - Company Value to EBITDA|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|RVTY: EV/EBITDA Multiple|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Nordion (SHC) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple QDEL|Enterprise Value to EBITDA Ratio opko.com OPK|EV/EBITDA Multiple MRVI (Maravai LifeSciences Holdings, Inc.)|EV/EBITDA Multiple Fulgent Genetics Inc FLGT|LAB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation CTKB (Cytek Corp)|OSUR: EV/EBITDA Multiple|Company Value to EBITDA Exagen (XGN)|MDXH (MDxHealth) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation LUCD (Lucid Diagnostics, Inc.)|Enterprise Value to EBITDA Ratio PRE (Prenetics Global)|imdxinc.com - Enterprise Value to Operating Income Before Depreciation|Trinity Biotech - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation PRPH|Ainos - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Co-Diagnostics Inc CODX|Heart Test Laboratories Inc. (HSCS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BMRA|CDIO (Cardio Diagnostics Holdings Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio onconetix.gcs-web.com (ONCO)|EV/EBITDA Multiple VRAX|Enterprise Value to EBITDA Ratio Bluejay Diagnostics Inc BJDX|EV/EBITDA Multiple AWH (Vermillion)|AXDX: Enterprise Value to Operating Income Before Depreciation|CNTG - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ENZ (Enzo Biochem, Inc.) - Enterprise Value to Operating Income Before Depreciation|FRES: EV/EBITDA Multiple|Genetic Technologies Limited (GENE) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization 23andMe Inc.|Enterprise Value to EBITDA Ratio Psychemedics Inc (PMD)